Cite

    Axelsen, M. et al. (2020). Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis. Scandinavian journal of rheumatology. pp. 105-111. [Online].